In vivo RNAi screening for novel therapeutic cancer targets

被引：0
|
作者：
Peeper, D. [1 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Oncol, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50025-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] RNAi screening for therapeutic targets in human malignancies
    Micklem, David R.
    Lorens, James B.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2007, 8 (06) : 337 - 343
  • [2] A RNAi screening to identify novel targets in cisplatin-resistant ovarian cancer
    Noriega, Ricardo
    Perez, Josue
    Vivas, Pablo
    FASEB JOURNAL, 2021, 35
  • [3] Association of high-throughput RNAi and drug screening with candidate novel therapeutic targets in esophageal carcinoma
    Chong, Irene Yu-Shing
    Hooper, Sean D.
    Cunningham, David
    Elliott, Richard
    Chen, Lina
    Campbell, James
    Bajrami, Ilirjana
    Kozarewa, Iwanka
    Wetterskog, Daniel
    Wilkerson, Paul M.
    Lambros, Maryou B.
    Rao, Sheela
    Starling, Naureen
    Chau, Ian
    Lord, Christopher J.
    Ashworth, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [4] RNAi Screening of the Tyrosine Kinome Identifies Therapeutic Targets in Leukemia Patients
    Tyner, Jeffrey W.
    Loriaux, Marc
    Willis, Stephanie G.
    Chang, Bill
    Bicocca, Vincent T.
    Oh, Stephen
    Hollink, Iris H. I. M.
    Segers, Stefanie
    den Boer, Monique L.
    Zwaan, C. M.
    Gotlib, Jason R.
    Deininger, Michael W. N.
    Druker, Brian J.
    BLOOD, 2008, 112 (11) : 281 - 281
  • [5] Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes
    Bjorkman, Mari
    Rantala, Juha
    Nees, Matthias
    Kallioniemi, Olli
    EPIGENOMICS, 2010, 2 (05) : 683 - 689
  • [6] Novel cancer therapeutic targets
    Hartman, GD
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 107 - 107
  • [7] Identification of novel immune checkpoints as potential therapeutic targets in pancreatic ductal adenocarcinoma (PDAC) using RNAi screening
    Sorrentino, Antonio
    Michels, Tillmann
    Menevse, Ayse Nur
    Khandelwal, Nisit
    Breinig, Marco
    Poschke, Isabel
    Offringa, Rienk
    Boutros, Michael
    Beckhove, Philipp
    CANCER RESEARCH, 2015, 75
  • [8] Negative Selection In Vivo RNAi Screening Identifies a Ribosomal Protein as a New Therapeutic Target in Liver Cancer
    Pesic, M.
    Wolter, K.
    Wuestefeld, T.
    Kang, T. -W.
    Chawla, R.
    Geffers, R.
    Klawonn, F.
    Malek, N.
    Schirmacher, P.
    Premsrirut, P. K.
    Longerich, T.
    Zender, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 100 - 100
  • [9] RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
    Tyner, Jeffrey W.
    Walters, Denise K.
    Willis, Stephanie G.
    Luttropp, Mary
    Oost, Jason
    Loriaux, Marc
    Erickson, Heidi
    Corbin, Amie S.
    O'Hare, Thomas
    Heinrich, Michael C.
    Deininger, Michael W.
    Druker, Brian J.
    BLOOD, 2008, 111 (04) : 2238 - 2245
  • [10] IDENTIFICATION OF THERAPEUTIC TARGETS IN DIPGS USING LARGE-SCALE RNAI SCREENING
    Schramm, Kathrin
    Iskar, Murat
    Sohn, Daniela
    Mack, Norman
    Hiddingh, Lotte
    Monje, Michelle
    Montero Carcaboso, Angel
    Zapatka, Marc
    Gronych, Jan
    Jones, David
    Lichter, Peter
    NEURO-ONCOLOGY, 2017, 19 : 9 - 9
12345